Capricor Therapeutics (CAPR) EBIT Margin Growth (1y) (2012 - 2024)
Capricor Therapeutics (CAPR) EBIT Margin Growth (1y) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Capricor Therapeutics | 457.86 Mn | 457.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -5,855.00 |
| Sep 30, 2024 | -46,427.00 |
| Jun 30, 2024 | -9,410.00 |
| Mar 31, 2024 | 17,138.00 |
| Dec 31, 2023 | 82,973.00 |
| Sep 30, 2023 | 29,603.00 |
| Jun 30, 2021 | 450,397.00 |
| Mar 31, 2021 | -1.15 Mn |
| Dec 31, 2020 | -656,113.00 |
| Sep 30, 2020 | -2.21 Mn |
| Jun 30, 2020 | -649,132.00 |
| Mar 31, 2020 | -2,556.00 |
| Dec 31, 2019 | -15,777.00 |
| Sep 30, 2019 | 75,716.00 |
| Jun 30, 2019 | 52,716.00 |
| Mar 31, 2019 | -18,799.00 |
| Dec 31, 2018 | 17,934.00 |
| Sep 30, 2018 | -106,083.00 |
| Jun 30, 2018 | 4,934.00 |
| Mar 31, 2018 | -51,659.00 |